GB/T 16886.1-2011 Part 1: Evaluation and Testing within a Risk Management Process

GB/T 16886.2-2011 Part 2: Animal Welfare Requirements

GB/T 16886.3-1997 Part 3: Tests for Genotoxicity, Carcinogenicity and Reproductive Toxicity

GB/T 16886.4-2003 Part 4: Selection of Tests for Interactions with Blood

GB/T 16886.5-2003 Part 5: Tests for In Vitro Cytotoxicity

GB/T 16886.6-1997 Part 6: Tests for Local Effects after Implantation

GB/T 16886.7-2001 Part 7: Ethylene Oxide Sterilization Residuals

GB/T 16886.9-2001 Part 9: Qualitative and Quantitative Framework for Potential Degradation Products

GB/T 16886.10-2000 Part 10: Tests for Irritation and Delayed-type Hypersensitivity

GB/T 16886.11-1997 Part 11: Systemic Toxicity Test

GB/T 16886.12-2005 Part 12: Sample Preparation and Reference Sample

GB/T 16886.13-2001 Part 13: Qualification and Quantification for Degradation Products of Polymer Medical Devices

GB/T 16886.14-2003 Part 14: Qualification and Quantification for Degradation Products of Ceramics

GB/T 16886.15-2003 Part 15: Qualification and Quantification for Degradation Products of Metals and Alloys

GB/T 16886.16-2003 Part 16: Toxicokinetics Study Design for Degradation Products and Solubles

GB/T 16886.17-2005 Part 17: Permissible Limit Establishment of Leachables

GB/T 16886.18-2011 Part 18: Chemical Characterization of Materials

GB/T 16886.19-2011 Part 19: Physical Chemistry, Morphology and Surface Property characterization of Materials